Mirror Now
@mirrornow·2.2M subscribers·145K videos
LNJP Medical Director Dr Suresh Kumar on ICRM study over 'Plasma therapy'
Posted
September 10, 2020
Views
87
Likes
4
Engagement
4.60%
September 10, 2020
87
4
4.60%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
3:40Now PlayingThe Plasma therapy didn't help in reducing death due to the coronavirus. The apex medical research has made these revelations to investigate the effectiveness of plasma therapy for the treatment of COVID-19 after conducting a study in 39 hospitals across India.
The study was conducted on 464 participants who were hospitalized and moderately ill confirmed COVID-19 patients, and these 464 patients were randomly enrolled. Out of which, about 235 participants were put in the intervention arm while 229 subjects were in the control arm.
"We have analysed the data of pilot study that it is very useful in a moderately sick patient. It is not useful in that patient who has multi-organ failure, a patient already on a ventilator or dialysis." says, Medical Director at LNJP & Principal Investigator of Plasma Therapy, Dr Suresh Kumar.
Watch!
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
